First of all, at any company, the investment in research and development in the products is the lifeblood, so that is a critical element of anyone's future going forward.
Sentiment: POSITIVE
The market is so competitive. There are so many products that are similar. So we are forced to invest in innovative research in new products that are one or two years ahead of the market.
Innovation requires resources to invest, and you can see many companies pulling back and going into an intense protective mode in a major extended period of financial distress.
If we're building high quality companies, if the customers like the products, if the technology innovation is real, then the substance is going to win out in the end.
I'm an investor in a number of biotech companies, partly because of my incredible enthusiasm for the great innovations they will bring.
You know, you want everything you do, obviously, to be a success critically and commercially. But what you find out as you go along is that everything won't.
The only way you survive is you continuously transform into something else. It's this idea of continuous transformation that makes you an innovation company.
A sustaining innovation makes better products that you can sell for better profits to your best customers.
Most companies don't have the luxury of focusing exclusively on innovation. They have to innovate while stamping out zillions of widgets or processing billions of transactions.
My passion for innovation and my interest in the 'business of science' has seen Biocon commercialize many innovative platforms and products.
One of the banes of successful innovation is that companies may be so committed to innovation that they will give the innovators a lot of money to spend.